✦ LIBER ✦

P-499 Prognostic relevance of 60 clinical factors, “classical” laboratoryparameters and tumor markers in patients with advanced non-small cell lung cancer

✍ Scribed by Holdenrieder, S.; von Pawel, J.; Raith, H.; Feldmann, K.; Stenman, U.; Nagel, D.; Stieber, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-491 Palliative chemotherapy (QT) and p

✍ Guerreroero Zotano, A.; Pellin Ariño, L.; Molina Saera, J.; Palomar Abad, L.; Po 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Telomerase activity and serum levels of

✍ Tomasz Targowski; Karina Jahnz-Rozyk; Witold Owczarek; Alicja Raczka; Pawel Jand 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Evaluation of CTLA-4 expression and rele

✍ Sandra Salvi, Vincenzo Fontana, Simona Boccardo, Domenico Franco Merlo, Edoardo 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 747 KB

Can mutations of EGFR and KRAS in serum

✍ Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Kyong Hwa Park, Sang Won Shin, Yeul Ho 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 300 KB

Validation of a clinical prognostic mode

✍ Fenghua Wang; Yang Zhang; Hongyun Zhao; Likun Chen; Yan-Xia Shi; Li Zhang 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 183 KB

Mutations in exon 7 and 8 of p53 as poor

✍ Huang, Cheng-long; Taki, Toshihiko; Adachi, Masashi; Konishi, Takaaki; Higashiya 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 357 KB